Molecular characterization of CD28 and cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) of woodchuck (Marmota monax)

Tissue Antigens

Volumn 62, Issue 3, 2003, Pages 225-232

  Yang, D ^a   Roggendorf, M ^a   Lu, Mengji ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Accessory molecules; CD28; Costimulation; CTLA 4; Woodchuck

Indexed keywords

ANTIBODY; CD28 ANTIGEN; COMPLEMENTARY DNA; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HEXAPEPTIDE; METHIONYLTYROSYLPROLYLPROLYLPROLYLTYROSINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DNA SEQUENCE; EXPRESSION VECTOR; GENE INTERACTION; HEPADNAVIRIDAE; IMMUNE RESPONSE; IMMUNOGENETICS; IMMUNOHISTOCHEMISTRY; IMMUNOSTIMULATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE; MAMMAL; MOLECULAR CLONING; MOLECULAR GENETICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN MOTIF; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; STRUCTURAL HOMOLOGY; WOODCHUCK;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, DIFFERENTIATION; BASE SEQUENCE; CLONING, MOLECULAR; CRICETINAE; DNA, COMPLEMENTARY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEPADNAVIRIDAE; HUMANS; LYMPHOCYTES; MARMOTA; MOLECULAR SEQUENCE DATA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; TRANSFECTION;

ANIMALIA; CYTOMEGALOVIRUS; HEPADNAVIRIDAE; HEPATITIS B VIRUS; MAMMALIA; MARMOTA; MARMOTA MONAX; VECTORS;

EID: 0141613171     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.2003.00086.x     Document Type: Article

References (54)

1. Tennant BC, Gerin JL. The woodchuck model of hepatitis B virus infection. In: Arias IM, et al., eds. The Liver: Biology, Pathobiology, Raven Press, New York, NY, 1994: 1455-66.
2. Roggendorf M, Tolle TK. The woodchuck: an animal model for hepatitis B virus infection in man. Intervirology 1995: 38: 100-2.
3. Cote PJ, Gerin JL. The woodchuck as a model of hepadnavirus infection, pathogenesis and therapy. Forum Trends Exp Clin Med 1996: 6: 6131-59.
4. Lu M, Roggendorf M. Evaluation of new approaches of prophylactic and therapeutic vaccinations to hepatitis B viruses in the woodchuck model. Intervirology 2001: 44: 214-23.
5. Cote PJ, Gerin JL. In vitro activation of woodchuck lymphocytes measured by radiopurine incorporation and interleukin-2 production: implications for modeling immunity and therapy in hepatitis B virus infection. Hepatology 1995: 22: 687-99.
6. Menne S, Maschke J, Lu M, Grosse-Wilde H, Roggendorf M. T-cell response to woodchuck hepatitis virus. WHV, antigens during acute self-limited WHV infection and convalescence and after viral challenge. J Virol 1998: 72: 6083-91.
7. Menne S, Maschke J, Tolle TK, Lu M, Roggendorf M. Characterization of T-cell response to woodchuck hepatitis virus core protein and protection of woodchucks from infection by immunization with peptides containing a T-cell epitope. J Virol 1997: 71: 65-74.
8. Menne S, Roneker CA, Roggendorf M, Gerin JL, Cote PJ, Tennant BC. Deficiencies in the acute-phase cell-mediated immune response to viral antigens are associated with development of chronic woodchuck hepatitis virus infection following neonatal inoculation. J Virol 2003: 76: 1769-80.
9. Nakamura I, Nupp JT, Rao BS et al. Cloning and characterization of partial cDNAs for woodchuck cytokines and CD3epsilon with applications for the detection of RNA expression in tissues by RT-PCR assay. J Med Virol 1997: 53: 85-95.
10. Lohrengel B, Lu M, Roggendorf M. Molecular characterization of woodchuck cytokines tumor necrosis factor alpha, interferon gamma and interleukin 6. Immunogenetics 1998: 43: 332-5.
11. Yang D, Lu M, Hao L, Roggendorf M. Molecular cloning and characterization of major histocompatibility complex class I cDNAs from woodchuck Woodchuck MHC class I. Tissue Antigens 2000: 55: 548-57.
12. Michalak TI, Hodgson PD, Churchill ND. Posttranscriptional inhibition of class I major histocompatibility complex presentation on hepatocytess and lymphoid cells in chronic woodchuck hepatitis virus infection. J Virol 2000: 74: 4483-94.
13. Zhou J, Ferencik S, Rebmann V et al. Molecular genetic and biochemical analysis of woodchuck (Marmota monax) MHC Class I polymorphism Tissue Antigens 2003: 61: 240-8.
14. Schwartz RH. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 1992: 71: 1065-8.
15. Linsley PS, Ledbetter JA. The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 1993: 11: 191-212.
16. June CH, Bluestone JA, Nadler LM, Thompson CB. The B7 and CD28 receptor families. Immunol Today 1994: 15: 321-31.
17. Waterhouse P, Marengere LE, Mittrucker HW, Mak TW. CTLA-4, a negative regulator of T-lymphocyte activation. Immunol Rev 1996: 153: 183-207.
18. Bluestone JA. Is CTLA-4 a master switch for peripheral T cell tolerance? J Immunol 1997: 158: 1989-93.
19. June CH, Ledbetter JA, Linsley PS, Thompson CB. Role of the CD28 receptor in T-cell activation. Immunol Today 1990: 11: 211-6.
20. Allison JP. CD28-B7 interactions in T-cell activation. Curr Opin Immunol 1994: 6: 414-9.
21. Brunet JF, Denizot F, Luciani MF et al. A new member of the immunoglobulin superfamily - CTLA-4. Nature 1987: 328: 267-70.
22. Linsley PS, Greene JL, Tan P et al. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J Exp Med 1992: 176: 1595-604.
23. Perkins D, Wang Z, Donovan C et al. Regulation of CTLA-4 expression during T-cell activation. J Immunol 1996: 156: 4154-9.
24. Linsley PS, Brady W, Urnes M, Grosmaire LS, Damle NK, Ledbetter JA. CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 1991: 174: 561-9.
25. Walunas TL, Bakker CY, Bluestone JA. CTLA-4 ligation blocks CD28-dependent T-cell activation. J Exp Med 1996: 183: 2541-50.
26. Walunas TL, Lenschow DJ, Bakker CY et al. CTLA-4 can function as a negative regulator of T-cell activation. Immunity 1994: 1: 405-13.
27. Allison JP, Krummel MF. The Yin and Yang of T cell costimulation. Science 1995: 270: 932-3.
28. Waterhouse P, Penninger JM, Timms E et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 1995: 270: 985-8.
29. Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995: 3: 541-7.
30. Krummel MF, Allison JP. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J Exp Med 1995: 182: 459-65.
31. Chambers CA, Krummel MF, Boitel B et al. The role of CTLA-4 in the regulation and initiation of T-cell responses. Immunol Rev 1996: 153: 27-46.
32. Pages F, Ragueneau M, Klasen S et al. Two distinct intracytoplasmic regions of the T-cell adhesion molecule CD28 participate in phosphatidylinositol 3-kinase association. J Biol Chem 1996: 271: 9403-9.
33. Pages F, Ragueneau M, Rottapel R et al. Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T- cell. Nature 1994: 369: 327-9.
34. Truitt KE, Hicks CM, Imboden JB. Stimulation of CD28 triggers an association between CD28 and phosphatidylinositol 3-kinase in Jurkat T cells. J Exp Med 1994: 179: 1071-6.
35. Stein PH, Fraser JD, Weiss A. The cytoplasmic domain of CD28 is both necessary and sufficient for costimulation of interleukin-2 secretion and association with phosphatidylinositol 3′-kinase. Mol Cell Biol 1994: 14: 3392-402.
36. Prasad KV, Cai YC, Raab M et al. T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr (P: Met-Xaa-Met motif. Proc Natl Acad Sci U S A 1994: 91: 2834-8.
37. Lu Y, Phillips CA, Bjorndahl JM, Trevillyan JM. CD28 signal transduction: tyrosine phosphorylation and receptor association of phosphoinositide-3 kinase correlate with Ca (2+: independent costimulatory activity. Eur J Immunol 1994: 24: 2732-9.
38. Schneider H, Prasad KV, Shoelson SE, Rudd CE. CTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cells. J Exp Med 1995: 181: 351-5.
39. Hutchcroft JE, Bierer BE. Signaling through CD28/CTLA-4 family receptors, puzzling participation of phosphatidylinositol-3 kinase. J Immunol 1996: 156: 4071-4.
40. Aruffo A, Seed B. Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system. Proc Natl Acad Sci U S A 1987: 84: 8573-7.
41. Linsley PS, Nadler SG, Bajorath J et al. Binding stoichiometry of the cytotoxic T lymphocyte-associated molecule-4. CTLA-4: a disulfide-linked homodimer binds two CD86 molecules. J Biol Chem 1995: 270: 15417-24.
42. Greene JL, Leytze GM, Emswiler J et al. Covalent dimerization of CD28/CTLA-4 and oligomerization of CD80/CD86 regulate T cell costimulatory interactions. J Biol Chem 1996: 271: 26762-71.
43. Boyle JS, Brady JL, Lew AM. Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction. Nature 1998: 392: 408-11.
44. Clark GJ, Dallman MJ. Identification of a cDNA encoding the rat CD28 homologue. Immunogenetics 1992: 35: 54-7.
45. Dariavach P, Mattei MG, Golstein P, Lefranc MP. Human Ig superfamily CTLA-4 gene: chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domains. Eur J Immunol 1988: 18: 1901-5.
46. Gross JA, St. John T, Allison JP. The murine homologue of the T lymphocyte antigen CD28. Molecular cloning and cell surface expression. J Immunol 1990: 144: 3201-10.
47. Harper K, Balzano C, Rouvier E, Mattei MG, Luciani MF, Golstein P. CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J Immunol 1991: 147: 1037-4.4.
48. Isono T, Seto A. Cloning and sequencing of the rabbit gene encoding T-cell costimulatory molecules. Immunogenetics 1995: 42: 217-20.
49. Oaks MK, Penwell RT, Tector AJ. Nucleotide sequence of the ACI rat CTLA-4 molecule. Immunogenetics 1996: 43: 173-4.
50. Parsons KR, Young JR, Collins BA, Howard CJ. Cattle CTLA-4, CD28 and chicken CD28 bind CD86: MYPPPY is not conserved in cattle CD28. Immunogenetics 1996: 43: 388-91.
51. Chaplin PJ, Pietrala LN, Scheerlinck JP. Cloning and sequence comparison of sheep CD28 and CTLA-4. Immunogenetics 1999: 49: 583-4.
52. Vaughan AN, Malde P, Rogers NJ, Jackson IM, Lechler RI, Dorling A. Porcine CTLA4-Ig lacks a MYPPPY motif, binds inefficiently to human B7 and specifically suppresses human CD4+ T-cell responses costimulated by pig but not human B7. J Immunol 2000: 165: 3175-81.
53. Khatlani TS, Ma Z, Okuda M, Onishi T. Molecular cloning and sequencing of canine T-cell costiulatory molecule (CD28). Vet Immunol Immunopathol 2001: 78: 341-8.
54. Villinger F, Bostik P, Mayne A et al. Cloning, sequencing and homology analysis of nonhuman primate Fas/Fas-ligand and co-stimulatory molecules. Immunogenetics 2001: 53: 315-28.